Suppr超能文献

监测细胞学病理质量项目中修改报告的价值:两年一次的审查。

The value of monitoring amended reports in cytopathology quality programs: A biennial review.

机构信息

Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.

出版信息

Cancer Cytopathol. 2022 Nov;130(11):860-871. doi: 10.1002/cncy.22607. Epub 2022 Jun 6.

Abstract

BACKGROUND

Quality and safety are the foundation of the practice of cytopathology. Review of key performance indicator (KPI) data can shine a light on laboratory vulnerabilities and potential areas for targeted improvement. The rate and content of amendment reports is a frequently monitored KPI in anatomic pathology, but few have studied its value in cytopathology. The goal of this study was to examine the frequency, classification, and outcome of amendments for a large cytopathology laboratory.

METHODS

All amendment reports issued for cases during a 2-year period from July 2019 to June 2021 were included in the study. Amendments were classified into three error type root causes: Specimen Identification Error, General Report Defects, and Diagnostic Error.

RESULTS

A total of 202 amendment reports were issued equating to a rate of 0.275%. A total of 83 (41.1%) were gynecologic cases and 119 (58.9%) were nongynecologic cases. Within the gynecologic cases, 13 (15.7%) cases were due to Specimen Identification Error, 13 (15.7%) cases were due to Diagnostic Error, and 57 (68.7%) cases were due to General Report Defects. Within the nongynecologic cases, 15 (12.6%) cases were due to Specimen Identification Error, 30 (25.2%) cases were due to General Report Defects, and 74 (62.2%) cases were due to Diagnostic Error with 32 of these due to true diagnostic change. Discovery methods included following re-review after additional clinical information was provided, reinterpretation after additional ancillary testing was performed, or conference review. There was no correlation with years in practice.

CONCLUSIONS

Studying amendment reports is an underrecognized and valuable quality assurance tool. Amendments can help provide information about types of errors, monitor laboratory processes, and help guide quality improvement endeavors.

摘要

背景

质量和安全是细胞病理学实践的基础。审查关键绩效指标(KPI)数据可以揭示实验室的脆弱性和潜在的改进领域。在解剖病理学中,修正报告的比率和内容是经常监测的 KPI,但很少有人研究其在细胞病理学中的价值。本研究的目的是检查一个大型细胞病理学实验室的修正报告的频率、分类和结果。

方法

本研究纳入了 2019 年 7 月至 2021 年 6 月期间发出的所有修正报告。将修正分为三种错误类型的根本原因:标本识别错误、一般报告缺陷和诊断错误。

结果

共发出 202 份修正报告,占 0.275%。其中 83 例(41.1%)为妇科病例,119 例(58.9%)为非妇科病例。在妇科病例中,13 例(15.7%)是由于标本识别错误,13 例(15.7%)是由于诊断错误,57 例(68.7%)是由于一般报告缺陷。在非妇科病例中,15 例(12.6%)是由于标本识别错误,30 例(25.2%)是由于一般报告缺陷,74 例(62.2%)是由于诊断错误,其中 32 例是由于真正的诊断改变。发现方法包括在提供额外的临床信息后进行重新审查、在进行额外的辅助检测后进行重新解释或会议审查。与实践年限无关。

结论

研究修正报告是一种被低估但有价值的质量保证工具。修正报告可以提供有关错误类型的信息,监测实验室流程,并有助于指导质量改进工作。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验